Oriana Zerbini – Chief Executive Officer
Dr Oriana Zerbini MD specialised in Cardiology, Pharmacology and in Tropical Medicine and Hygiene at Padua, Modena and London Universities, respectively. She also received a Masters degree in Communication Skills from Bocconi University in Milan. Dr Zerbini spent twelve years working for a major international Pharmaceutical company where she was primarily responsible for leading clinical research programmes at national and international level.
Oriana is the Medical Director of CROMSOURCE, the company which she founded over 20 years ago. In this time she has lent her experience and expertise to many national and international clinical trials. These trials have been conducted for sponsor organisations of all sizes and at all phases of development. Her therapeutic area experience includes (but is not limited to) oncology, respiratory, cardiovascular, metabolic, rheumatology, CNS, infective disease, cardiology and vaccines. Oriana is also a key organiser in CROMSOURCE’s international development and over the last few years has established several European and North American strategic alliances.
Carlo Zerbini – Chief Financial Officer
Carlo Zerbini has more than 30 years’ experience in the finance field. Before joining CROMSOURCE, he gained experience in the Accounting and HR divisions in the previous working experiences. In 2002 he started to work for CROMSOURCE as Finance & Human Resource Manager Director; from February 2011 has been appointed as Chief Financial Officer (CFO) with the responsibility for the financial management of CROMSOURCE.
Troy W. McCall - Chief Operating Officer
Dr. McCall has more than twenty-five years of experience in the pharmaceutical and CRO industries, having worked for more than a decade each in increasingly senior positions in specialty pharma and life science services companies. He has a proven track record of success in leading and growing start-up, small, and medium-sized organizations. He has been a managing partner and/or CEO at four companies.
Dr. McCall has consistently been successful in building value through a disciplined business approach which includes, but is not limited to, cost rationalization and expense management resulting in industry-leading margins, hands-on and effective engagement with clients, FDA, and other stakeholders, active participation with the sales and marketing organizations to significantly improve top-line results, and top-grading talent at all levels. He has extensive experience with growing and transforming companies and developing successful, sustainable organizations.
In addition to his roles in pharmaceutical and life science services companies, Dr. McCall has served as an advisor to private equity firms to support their investment activities, both for potential new investments as well as providing guidance to their existing portfolio companies. He also served as a Senior Advisor to The Reagan-Udall Foundation for the Food and Drug Administration where he led multiple initiatives supporting the FDA’s mission to promote and protect public health. One such initiative was the Innovation in Medical Evidence Development and Surveillance (IMEDS) program, a public-private partnership comprised of a variety of stakeholders (FDA, regulated industry, academia, advocates, and others) with the goal of optimizing the way in which large observational healthcare datasets are managed to improve the safety of marketed medical products.
Simona Colazzo - Executive Director
Simona was awarded a degree in Biological Science at the University of Parma. She joined CROMSOURCE in 2002, starting her career in pharmacovigilance and then leading numerous national and international clinical trials in various therapeutic areas as a project manager. She then focused on quality assurance management, performing more than fifty in-house and on-site national and international audits. After eight years of progressive management experience she became Executive Director of CROMSOURCE, responsible for the successful management of the organization according to the company vision and corporate strategy.
Debbie Kent - Global Head of TalentSource Life Sciences
Debbie joined CROMSOURCE in 2016 as Global Head of TalentSource Life Sciences Department, the CROMSOURCE flexible resourcing Department. In this role, she heads up an international team, working directly with clients, coupled with the leadership of the Talent Acquisition Unit. She has worked in the pharmaceutical industry since 1992 with prior roles as Head of Insourcing at one of the top 3 CROs, encompassing the Strategic Management and development of the Functional Services Department and as Head of Marketing, Business Development and Staffing in a niche data management and biometrics provider. Debbie has global management experience, leading a large management team throughout Europe, Asia and the Americas. Debbie studied marketing and business in the UK and is focused on client satisfaction and leadership excellence.
Kerry Dyson - Global Head Clinical Research Division
Kerry Dyson was awarded an MSc and PhD in exercise physiology from McMaster University (Canada) and Leeds Metropolitan University (UK), respectively. After a brief academic career he joined the industry in 1999 with Innovex Ltd (part of the Quintiles group). He then worked in roles of increasing seniority within operational clinical development at Innovex and Novartis pharmaceuticals until joining Catalyst Pharma Group (CPG) in 2003, becoming Head of EU Operations in 2004. Kerry’s focus then moved from purely operational activities to include strategic and corporate developmental responsibilities.
A large part of this role involved marketing and business development in across Europe and the USA. After providing significant support to the sale of the major part of CGP’s business to ICON plc, Kerry joined CROMSOURCE in 2008 with responsibility for contribution to corporate strategy, leading UK operations and business development. In 2011 Kerry became Director of Marketing and Communications whilst also retaining his role as Head of UK Operations. In 2016 Kerry transitioned into another leadership role at CROMSOURCE, becoming Global Head of the Clinical Research Division. In this role Kerry is responsible for the oversight of all aspects of the delivery of clinical research services, ensuring the highest standards of quality, timeliness and accountability are delivered to CROMSOURCE clients.
Antoinette Torres Frankum - Executive Director Clinical Research Division
Antoinette has over 20 years’ experience leading teams and managing complex clinical trials in the Biotech, Pharma, and Medical Device Industry. At CROMSOURCE, Antoinette is part of the Executive team and has been instrumental in developing the US operations, as well as directing global clinical research activities. Her passion for building high performing teams, improving the operational value chain, and being a part of the science to improve lives, drives her commitment to the industry. Therapeutic expertise includes but is not limited to: Rare Disease, Respiratory, CNS, Endocrinology, and Ophthalmology. Antoinette received her Bachelors Degree and Executive Management Certification from University of California, Los Angeles. She is a speaker and contributor at industry related organizations and conferences, and is a professional member of the Project Management Institute (PMI), Women in Bio (WIB), Healthcare Business Woman’s Association, Drug Information Association (DIA) and Association of Clinical Research Professionals (ACRP).
David Jackson - Director Biometrics Division
David Jackson earned his Statistics BSc. Hons. from The University of Glasgow and his MSc. in Statistics from the University of Sheffield. As a statistician he continues to take a special interest in the statistical challenges in complex trials where there is high dependence of multiple within patient observations (such as ophthalmic trials using data from both eyes). After a brief career in the service industry he joined the pharmaceutical industry in 2002, working as a statistician across all Phases for a major CRO. Spending a significant time with a biometrics specialist CRO and having always worked as a service provider has given David the insight into how full service and FSP models can support the pharmaceutical and medical device industries and of the importance of meeting our customer’s needs.
David joined CROMSOURCE in 2010 and as Head of the Biostatistics and Programing group oversaw the growth of the department and the streamlining of procedures to better meet the needs of our pharmaceutical and medical device sponsors. As Head of the Biometrics department David continues to support continual improvements to exceed our sponsor expectations. David is experienced across all areas of product development from statistical consultancy to FDA and EMA submission. David has represented our Sponsors at FDA (CDER, CBER and CDRH) and EMA meetings, interactions, audits and inspections and is comfortable advising and presenting on all biometrics aspects across a range of therapeutic areas. David’s skills are evident in communicating often complex biometrics procedures in non-complex language removing the fear from biometrics and opening the ‘black box’ for our sponsors.
David Dills - Director Regulatory Services
David joined CROMSOURCE in 2018 as Regulatory Services Department Director. He has more than 29 years’ of leadership experience in the biopharmaceutical and medical device industry within the regulatory affairs and compliance space. He has held positions of increasing responsibility with sponsors and service providers of various sizes, including large, global OEM’s/sponsors, consultancies and a global CRO, as well as virtual, small, mid and large-sized enterprises.
He has worked with clients in ASEAN/APAC, EMEA and The Americas, and certainly with FDA and the global Health Authorities/CA’s involving a wide spectrum of product portfolios covering multiple therapeutic areas and medical specialties. He interprets the regulatory precedents and new legislation, understands the competitive landscape and conducts persuasive communications and meetings with the regulatory authorities while executing an effective regulatory strategy and path to regulatory approval. He is providing the global regulatory capabilities and regulatory intelligence support for clients, strategic and operational support for clinical operations, and collaborating with our internal stakeholders and business partners.
In addition, to being a professional member with industry associations, advisory boards, and a prolific speaker at industry events, he navigates the regulatory landscape throughout the product life cycle from premarketing, postmarketing to commercialization with regulatory oversight and regulatory crisis management. In addition, David is responsible for the development and deployment of new services in the Regulatory and Strategic Regulatory Consulting space and looks forward to providing strategic and tactical solutions that facilitate the achievement of regulatory and compliance milestones for our clients with proactive strategies to mitigate compliance exposure.
Margherita Mosconi - Chief Services Officer
Margherita Mosconi was awarded a BSc in Biological Science at the University of Pavia in 1990. She then joined a major global pharmaceutical company as a CRA and over the subsequent eleven years progressed through roles in national and international project management. In 2005 Margherita then joined CROMSOURCE as Clinical Research Operations Director overseeing the operational delivery of hundreds of trials at all phases of development.
From 2007 to 2016, Margherita has successfully overseen and expanded the global business development establishing many successful client relationships and strategic partnerships. She was responsible for driving the Company’s business growth leading the Business Development Department and the Marketing & Communication Department. After almost ten years spent in the commercial field, from March 2017 she drives the Corporate Communication contributing to share CROMSOURCE mission, vision and values. Moreover she is responsible for the development of new services in the Regulatory and Consulting area and supports the Senior Management in guaranteeing the efficiencies and effectiveness of the operational and commercial processes.
Silvio Severini - Managing Director of Techorizon
Silvio joined CROMSOURCE in 2001 first as a clinical monitor then as a project manager for diabetic’s clinical trials, developing a strong expertise and experience in the Clinical Operations Processes. In 2004 he became responsible for the Procurement Unit. In 2005 he became head of the IT unit of the group where, together with his team, he started to develop specific tools for the management and conduct of clinical trials. In 2009, he co-founded Techorizon, an IT company of the CROMSOURCE Group that focuses on the development of tools for the pharmaceutical industry, proposing them to a wider market. Today, with the Techorizon team, he continues to develop and offer its customers the Techorizon Clinical platform that provides valuable tools in conducting and collecting data for clinical trials.
Interested in working with CROMSOURCE?
CROMSOURCE offers its employees opportunities to build up a versatile
expertise by working on different projects. Aside day-to-day work, most of our employees are involved in interdisciplinary projects aiming to respond to our customers needs better by improving existing processes and contributing to the development of new procedures, products, internal IT applications, etc.
Additionally, employees of
CROMSOURCE are also rewarded with development opportunities as a high percentage of them are promoted or have changed to another role during their time at CROMSOURCE.
CROMSOURCE have built a strong and deserved reputation based on professionalism, responsibility and proactiveness. Their teams are completely dedicated, highly professional and responsible, with good analytical skills. I would recommend CROMSOURCE unreservedly to anyone seeking support with aspect of their clinical development projects.